West Pharmaceutical Services Inc
NYSE:WST
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
276.9749
413
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
Abbvie Inc
NYSE:ABBV
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Realty Income Corp
NYSE:O
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one WST stock under the Base Case scenario is 224.87 USD. Compared to the current market price of 312.28 USD, West Pharmaceutical Services Inc is Overvalued by 28%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
West Pharmaceutical Services Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for WST cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Price Target |
Loading
|
Revenue Forecast |
|
Operating Income Forecast |
|
Earnings Forecast |
|
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
West Pharmaceutical Services Inc. is a leading global manufacturer of advanced drug delivery systems and medical device components, catering primarily to the pharmaceutical and biotechnology sectors. Founded in 1923, the company has built a robust reputation for its innovative solutions that enhance the safety and efficacy of medications. With a focus on producing high-quality packaging and delivery systems, West’s product lineup includes prefillable syringes, stoppers, and highly specialized devices that contribute to the growing demand for biologics and complex medications. This focus on quality has positioned West as a trusted partner for major pharmaceutical companies, and its strategic...
West Pharmaceutical Services Inc. is a leading global manufacturer of advanced drug delivery systems and medical device components, catering primarily to the pharmaceutical and biotechnology sectors. Founded in 1923, the company has built a robust reputation for its innovative solutions that enhance the safety and efficacy of medications. With a focus on producing high-quality packaging and delivery systems, West’s product lineup includes prefillable syringes, stoppers, and highly specialized devices that contribute to the growing demand for biologics and complex medications. This focus on quality has positioned West as a trusted partner for major pharmaceutical companies, and its strategic global footprint allows it to meet the rising demands of health systems worldwide.
As the healthcare landscape evolves, West Pharmaceutical Services stands to benefit from several key industry trends, including the increased emphasis on patient-centric therapies and the demand for reliable and efficient drug administration methods. Investors can find assurance in the company’s commitment to innovation, as it invests heavily in research and development to stay ahead of emerging trends and regulatory changes. Additionally, West’s consistent financial performance, with steady revenue growth and healthy profit margins, showcases its resilience and operational efficiency. As the biopharmaceutical market continues to expand, West’s strategic alignment with cutting-edge therapeutic developments positions it well for future growth, painting a promising picture for potential investors looking to tap into the burgeoning healthcare sector.
West Pharmaceutical Services, Inc. is a leading global manufacturer of packaging and delivery solutions for injectable drugs and therapies. The company's core business segments can be broadly categorized into the following areas:
-
Pharmaceutical Packaging Systems:
- This segment involves the design and production of primary packaging components such as prefillable syringes, vials, and elastomeric closures. These products are critical for ensuring the integrity, safety, and efficacy of injectable medications.
-
Delivery Systems:
- West provides a range of delivery systems that include syringe and pen delivery systems designed for patient self-administration. This segment focuses on solutions that enhance the user experience and provide convenience for both patients and healthcare providers.
-
Contract Manufacturing:
- West also offers contract manufacturing services, allowing pharmaceutical companies to outsource the production of certain components and systems. This segment supports clients in meeting their manufacturing needs, particularly for complex and highly regulated products.
-
Biocompatibility Testing and Development:
- The company invests in the development of innovative materials and conducts biocompatibility testing to ensure that their products meet regulatory requirements and safety standards for healthcare applications.
-
Molecular Diagnostic Solutions:
- In recent expansions, West has focused on the development of solutions for molecular diagnostics, providing components that support the growing trend of personalized medicine.
-
Customer Solutions and Technical Services:
- West offers consultancy and technical services as part of their overall solutions, assisting clients in selecting the right systems and materials, as well as offering support for regulatory compliance and process optimization.
These segments illustrate West Pharmaceutical Services' commitment to supporting the biotech and pharmaceutical industries with high-quality products that enhance drug delivery and ensure patient safety. The company's strong focus on innovation and quality control is aimed at meeting the evolving needs of its customers.
West Pharmaceutical Services, Inc. possesses several unique competitive advantages that differentiate it from its rivals in the pharmaceutical packaging and delivery system industry:
-
Established Reputation and Brand Trust: West has a long-standing history and reputation for quality and reliability in the pharmaceutical sector. This trust is critical in industries where safety and efficacy are paramount.
-
Strong R&D Capabilities: The company invests significantly in research and development to innovate and improve its product offerings. Its focus on developing advanced drug delivery systems and packaging technologies helps it stay ahead of competitors.
-
Comprehensive Product Portfolio: West offers a diverse range of products, including drug delivery systems, containment solutions, and ancillary products. This comprehensive portfolio allows it to serve various customer needs and reduce dependency on any single product line.
-
Global Manufacturing and Supply Chain Network: With facilities located worldwide, West can effectively meet the demands of a global customer base. This network enables flexibility, reduced lead times, and the ability to respond swiftly to market changes.
-
Focus on Biologics and Specialty Drugs: As the market shifts toward biologic and specialty pharmaceuticals, West’s expertise in these areas positions it well for future growth. Its products are designed to accommodate the unique requirements of these complex drugs.
-
Customer-Centric Approach: West engages closely with its clients throughout the product development and implementation process. This collaboration fosters strong relationships and loyalty, making it more challenging for competitors to lure clients away.
-
Regulatory Expertise: The company has extensive experience navigating complex regulatory environments. This expertise ensures compliance and helps clients expedite their product approvals, enhancing West's attractiveness as a partner.
-
Sustainability Initiatives: West is increasingly focusing on sustainable practices, responding to the growing demand for environmentally friendly solutions in packaging and manufacturing. This commitment can enhance brand loyalty and attract customers looking for eco-conscious suppliers.
-
Robust Intellectual Property: With a strong portfolio of patents and proprietary technologies, West protects its innovations, making it difficult for competitors to replicate its unique offerings.
-
Strategic Acquisitions: West has a history of strategic acquisitions to enhance its capabilities and expand its footprint. This strategy allows the company to integrate new technologies and products that complement its existing offerings.
These factors combine to create a significant competitive edge for West Pharmaceutical Services, positioning it as a leader in the pharmaceutical services industry.
West Pharmaceutical Services Inc., being a leader in the development and manufacturing of drug delivery systems and biologics, faces several risks and challenges in the near future. Some key considerations include:
-
Market Competition: The biopharmaceutical industry is highly competitive, with numerous players entering the market. These competitors may offer innovative products or technologies that could disrupt West’s market share.
-
Regulatory Challenges: The pharmaceutical and medical device sectors are heavily regulated. Changes in regulations or increased scrutiny from agencies like the FDA can complicate product development and approval processes, delaying product launches and increasing compliance costs.
-
Supply Chain Disruptions: Any disruptions in the supply chain, be it due to geopolitical tensions, natural disasters, or logistical challenges, can impact manufacturing processes and delivery timelines, affecting revenue and customer satisfaction.
-
Technological Advancements: Rapid advancements in technology may require West to continuously innovate and invest in R&D to keep pace with emerging trends, such as digital health solutions and next-generation biologics.
-
Economic Factors: Economic downturns can affect funding and investment in research and development by biopharma companies, potentially leading to reduced demand for West’s products.
-
Pricing Pressure: As healthcare costs come under scrutiny, there may be increased pressure on pharmaceutical companies to lower prices, which could trickle down to West in terms of pricing pressure on their products.
-
Talent Acquisition and Retention: The need for skilled professionals in biotechnology and engineering is high. Challenges in attracting and retaining talent can hinder innovation and operational efficiency.
-
Intellectual Property Challenges: The need to protect intellectual property while navigating intricate patent laws can pose risks. Litigation related to patents can lead to increased costs and uncertainties.
-
Sustainability Issues: There is a growing emphasis on sustainability and environmental responsibility. West may face pressure to adopt more sustainable practices, which could involve significant investments.
-
Global Health Events: The recent pandemic highlighted vulnerabilities in global health systems. Future public health crises could affect demand patterns and operational stability.
Overall, West Pharmaceutical Services faces a complex landscape of risks and challenges that require strategic management and foresight to navigate successfully.
Revenue & Expenses Breakdown
West Pharmaceutical Services Inc
Balance Sheet Decomposition
West Pharmaceutical Services Inc
Current Assets | 1.5B |
Cash & Short-Term Investments | 446.2m |
Receivables | 479.4m |
Other Current Assets | 557.4m |
Non-Current Assets | 2B |
Long-Term Investments | 198.2m |
PP&E | 1.6B |
Intangibles | 120.2m |
Other Non-Current Assets | 53m |
Current Liabilities | 633.7m |
Accounts Payable | 211.7m |
Accrued Liabilities | 103.2m |
Other Current Liabilities | 318.8m |
Non-Current Liabilities | 278.9m |
Long-Term Debt | 75.3m |
Other Non-Current Liabilities | 203.6m |
Earnings Waterfall
West Pharmaceutical Services Inc
Revenue
|
2.9B
USD
|
Cost of Revenue
|
-1.9B
USD
|
Gross Profit
|
1B
USD
|
Operating Expenses
|
-422.7m
USD
|
Operating Income
|
604m
USD
|
Other Expenses
|
-79.1m
USD
|
Net Income
|
524.9m
USD
|
Free Cash Flow Analysis
West Pharmaceutical Services Inc
USD | |
Free Cash Flow | USD |
The company faced a mid-single-digit decline in organic sales in Q2 2024, with net sales of $702.1 million, a 5.9% decrease driven by customer destocking. This impacted key product lines like Westar and Daikyo Crystal Zenith, leading to a 690 basis point drop in the gross profit margin for proprietary products. Despite these setbacks, the company expects better performance in the second half of 2024. The full-year sales guidance has been adjusted to $2.87 billion to $2.9 billion with an EPS range of $6.35 to $6.65. Capital expenditures for the year are projected at $375 million, up from previous estimates.
What is Earnings Call?
WST Profitability Score
Profitability Due Diligence
West Pharmaceutical Services Inc's profitability score is 62/100. The higher the profitability score, the more profitable the company is.
Score
West Pharmaceutical Services Inc's profitability score is 62/100. The higher the profitability score, the more profitable the company is.
WST Solvency Score
Solvency Due Diligence
West Pharmaceutical Services Inc's solvency score is 83/100. The higher the solvency score, the more solvent the company is.
Score
West Pharmaceutical Services Inc's solvency score is 83/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
WST Price Targets Summary
West Pharmaceutical Services Inc
According to Wall Street analysts, the average 1-year price target for WST is 360.25 USD with a low forecast of 267.65 USD and a high forecast of 493.5 USD.
Shareholder Yield
Current shareholder yield for WST is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
WST Price
West Pharmaceutical Services Inc
Average Annual Return | 25.98% |
Standard Deviation of Annual Returns | 59.57% |
Max Drawdown | -56% |
Market Capitalization | 22.7B USD |
Shares Outstanding | 74 000 000 |
Percentage of Shares Shorted | 2.24% |
Ownership
WST Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
West Pharmaceutical Services, Inc. manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. The company is headquartered in Exton, Pennsylvania and currently employs 10,065 full-time employees. The firm operates through two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services and solutions, primarily to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
Contact
IPO
Employees
Officers
The intrinsic value of one WST stock under the Base Case scenario is 224.87 USD.
Compared to the current market price of 312.28 USD, West Pharmaceutical Services Inc is Overvalued by 28%.